نتایج جستجو برای: angiogenesis inhibitors

تعداد نتایج: 223931  

Journal: :Pharmaceutics 2021

Vascular endothelial growth factors (VEGFs) are the family of extracellular signaling proteins involved in processes angiogenesis. VEGFA overexpression and altered regulation pathways lead to pathological angiogenesis, which contributes progression various diseases, such as age-related macular degeneration cancer. Monoclonal antibodies decoy receptors have been extensively used anti-angiogenic ...

 Cerebrovascular disease is one of the leading causes of death in the world, and about one-fourth of cerebrovascular deaths are due to ruptured cerebral aneurysms (CA). Hence it is important to find a way to reduce aneurysm formation and its subsequent morbidity and mortality. Proteolytic activity capable of lysing gelatin has been shown to be increased in aneurysm tissue and expressio...

Journal: :ACS omega 2023

Non-small cell lung carcinoma (NSCLC) is the most common cancer globally. Phytochemicals and small molecule inhibitors significantly prevent varying types of cancers, including NSCLC. These therapeutic molecules serve as important sources for new drugs that interfere with cellular proliferation, apoptosis, metastasis, angiogenesis by regulating signaling pathways. affect several cascades, p53, ...

Journal: :BMC Biotechnology 2007
Bastien Hermant Agnès Desroches-Castan Marie-Laure Dubessay Marie-Hélène Prandini Philippe Huber Daniel Vittet

BACKGROUND Angiogenesis assays are important tools for the identification of regulatory molecules and the potential development of therapeutic strategies to modulate neovascularization. Although numerous in vitro angiogenesis models have been developed in the past, they exhibit limitations since they do not recapitulate the entire angiogenic process or correspond to multi-step procedures that a...

Journal: :Current pharmaceutical design 2003
M Presta D Leali H Stabile R Ronca M Camozzi L Coco E Moroni S Liekens M Rusnati

Angiogenesis is the process of generating new capillary blood vessels. Uncontrolled endothelial cell proliferation is observed in tumor neovascularization and in angioproliferative diseases. Tumors cannot growth as a mass above few mm(3) unless a new blood supply is induced. It derives that the control of the neovascularization process may affect tumor growth and may represent a novel approach ...

Journal: :Actas urologicas espanolas 2014
M Gökhan-Köse Ş R Erdem Ç L Peşkircioğlu B Çaylak

INTRODUCTION It has been reported that varicocele might promote angiogenesis. However, it is not clearly identified how angiogenesis affect testicular morphology or spermatogenic activity. The objective of the study is to investigate the effect of spironolactone, as an angiogenesis inhibitor, on the ipsilateral testis morphology in left varicocele-induced rats. MATERIALS AND METHODS Twenty fo...

Journal: :Journal of immunotherapy 2004
Donald M McDonald Beverly A Teicher William Stetler-Stevenson Sylvia S W Ng William D Figg Judah Folkman Douglas Hanahan Robert Auerbach Michael O'Reilly Roy Herbst David Cheresh Michael Gordon Alexander Eggermont Steven K Libutti

The field of tumor angiogenesis has seen explosive growth over the last 5 years. Preclinical as well as early clinical evaluation of novel compounds is progressing at a rapid pace. To gain a perspective on the field and to take stock of advances in the understanding of molecular mechanisms underlying the process of tumor angiogenesis as well as ways of monitoring the activity of agents, the Soc...

Journal: :Cancers 2021

The formation of new blood (angiogenesis) and lymphatic (lymphangiogenesis) vessels are major events associated with most epithelial malignancies, including breast cancer. Angiogenesis is essential for cancer cell survival. Lymphangiogenesis critical in maintaining tumoral interstitial fluid balance importing tumor-facilitatory immune cells. Both vascular routes also serve as conduits metastasi...

2000
Saroja Ramanujan Gerald C. Koenig Timothy P. Padera Brian R. Stoll Rakesh K. Jain

Solid tumors produce both stimulators and inhibitors of angiogenesis. The suppression of metastases by some primary tumors has been attributed to the longer circulatory half-lives of the inhibitors. We propose that intrinsic differences in the physicochemical properties of these regulators may also explain focal suppression of angiogenesis within the primary tumor. We present a mathematical fra...

Journal: :Cancer research 2000
S Ramanujan G C Koenig T P Padera B R Stoll R K Jain

Solid tumors produce both stimulators and inhibitors of angiogenesis. The suppression of metastases by some primary tumors has been attributed to the longer circulatory half-lives of the inhibitors. We propose that intrinsic differences in the physicochemical properties of these regulators may also explain focal suppression of angiogenesis within the primary tumor. We present a mathematical fra...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید